KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Construction in Progress (2023 - 2024)

Historic Construction in Progress for Edwards Lifesciences (EW) over the last 2 years, with Q4 2024 value amounting to $244.0 million.

  • Edwards Lifesciences' Construction in Progress fell 1658.12% to $244.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $244.0 million, marking a year-over-year decrease of 1658.12%. This contributed to the annual value of $244.0 million for FY2024, which is 1658.12% down from last year.
  • Edwards Lifesciences' Construction in Progress amounted to $244.0 million in Q4 2024, which was down 1658.12% from $292.5 million recorded in Q4 2023.
  • Edwards Lifesciences' Construction in Progress' 5-year high stood at $292.5 million during Q4 2023, with a 5-year trough of $244.0 million in Q4 2024.